311 related articles for article (PubMed ID: 33389016)
21. Role of CD47 in tumor immunity: a potential target for combination therapy.
Huang J; Liu F; Li C; Liang X; Li C; Liu Y; Yi Z; Zhang L; Fu S; Zeng Y
Sci Rep; 2022 Jun; 12(1):9803. PubMed ID: 35697717
[TBL] [Abstract][Full Text] [Related]
22. Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.
Zhang K; Xu Y; Chang X; Xu C; Xue W; Ding D; Nie M; Cai H; Xu J; Zhan L; Han J; Cai T; Ju D; Feng L; Zhang X; Yin K
Cancer Immunol Immunother; 2024 Mar; 73(4):75. PubMed ID: 38532108
[TBL] [Abstract][Full Text] [Related]
23. CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
Yoshida K; Tsujimoto H; Matsumura K; Kinoshita M; Takahata R; Matsumoto Y; Hiraki S; Ono S; Seki S; Yamamoto J; Hase K
Cancer Med; 2015 Sep; 4(9):1322-33. PubMed ID: 26077800
[TBL] [Abstract][Full Text] [Related]
24. Elevated
Wang D; Deng L; Xu X; Ji Y; Jiao Z
Genet Test Mol Biomarkers; 2021 Mar; 25(3):236-246. PubMed ID: 33734892
[No Abstract] [Full Text] [Related]
25. A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments.
Benesova I; Capkova L; Ozaniak A; Pacas P; Kopeckova K; Galova D; Lischke R; Buchler T; Ozaniak Strizova Z
J Cancer Res Clin Oncol; 2024 Mar; 150(3):134. PubMed ID: 38493445
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.
Liu H; Shen Z; Wang X; Zhang H; Qin J; Qin X; Xu J; Sun Y
Tumour Biol; 2016 Mar; 37(3):3285-93. PubMed ID: 26438062
[TBL] [Abstract][Full Text] [Related]
27. Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Hu H; Chen H
J Cancer Res Clin Oncol; 2021 Mar; 147(3):739-747. PubMed ID: 33392661
[TBL] [Abstract][Full Text] [Related]
28. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
Wang D; Jiao Z; Ji Y; Zhang S
J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
[TBL] [Abstract][Full Text] [Related]
29. Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer.
Xu Y; Li J; Tong B; Chen M; Liu X; Zhong W; Zhao J; Wang M
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32830120
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
Wang L; Zhao J; Yang C; Kuang R; Kazobinka G; Pang Z; Hou T
Cell Physiol Biochem; 2018; 48(6):2364-2373. PubMed ID: 30114689
[TBL] [Abstract][Full Text] [Related]
31. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z
Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460
[TBL] [Abstract][Full Text] [Related]
32. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
[TBL] [Abstract][Full Text] [Related]
33. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy.
Yang Z; Xu J; Li R; Gao Y; He J
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3055-3065. PubMed ID: 31522278
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; BrĂ¼ning T; Koch S; Roggisch J; Wirtz RM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy.
Zhou Y; Zeng J; Zhou W; Wu K; Tian Z; Shen W
Scand J Immunol; 2022 Oct; 96(4):e13198. PubMed ID: 35703112
[TBL] [Abstract][Full Text] [Related]
38. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
39. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]